Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

IMMEEDIA

Financiado

Cerrado

Immunomodulatory Effects of Exercise in Type 1 Diabetes

Diabetes is a major metabolic disease with huge costs for healthcare system throughout the EU and worldwide. Type 1 Diabetes (T1DM) is a chronic condition in which pancreas produces little or no insulin, believed to result from a... ver más

30/06/2014

UMIL

583K€

Presupuesto del proyecto: 583K€

Líder del proyecto

UNIVERSITA DEGLI STUDI DI MILANO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 5 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-06-30 No tenemos la información de la convocatoria

0% 69% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

5 Participantes

UMIL

0.00€ | Lider

OSR

N.D. | Participante

Proyectos interesantes

MIELT1D

Medical Technol...

Immunology

119K€ Cerrado

GLUCOTOX

Medical Technol...

Data Science

183K€ Cerrado

SAF2012-38830

Medical Technol...

Diabetes Resear...

82K€ Cerrado

MACROPHAGES IN T1D

Medical Technol...

Immunology

100K€ Cerrado

DIABIMMUNE

Medical Technol...

Public Health

8M€ Cerrado

PID2021-123377OB-I00

Medical Technol...

Data Science

218K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSITA DEGLI STUDI DI MILANO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 583K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Diabetes is a major metabolic disease with huge costs for healthcare system throughout the EU and worldwide. Type 1 Diabetes (T1DM) is a chronic condition in which pancreas produces little or no insulin, believed to result from a disorder of immunoregulation. For decades it has been known that regular aerobic exercise improves insulin sensitivity in diabetic patients, reducing insulin requirements. Traditionally, physical exercise has been promoted in type 2 diabetes, where insulin action is deficient in the context of insulin resistance and/or inappropriate insulin secretion. However, even in T1DM, in the dysregulation of immune system function, beta-cell toxicity is mediated by a complex interplay between oxidative stress and inflammation, for which exercise could be protective. Preliminary observations in fact indicate that regularly exercising T1DM-subjects have lower autoimmunity markers at an early stage of the disease. We want to ascertain the effect of moderate regular exercise as the most convenient measure to avoid the onset/worsening of T1DM. To verify whether exercise is capable of countering the T1DM-autoimmune process directed against beta-cells of the pancreatic islets, a multi-centric study will include: a) administration of a tailored exercise training program in different cohorts of T1DM-subjects; b) in-vivo animal experiments in which gain/loss-function models will be challenged with exercise; c) cell studies to analyse the exercise effects on signal transduction pathways and cytokine responses; d) metabolic profiling and metabolomic studies concerning the multicomponent analysis of biological fluids, tissue and cell extracts. Our consortium, through this multi-approach strategy, will reveal how exercise may exert a potent immunomodulatory effect, reducing the autoimmune response that in T1DM attacks and destroys the insulin producing cells.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores